Principal Financial Group Inc Absci Corp Transaction History

Principal Financial Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.58 - $3.41 $933 - $2,015	591 Added 2.67%	22,699 $39,000
Q4 2022 Feb 09, 2023	BUY	$2.0 - $3.58 $11,812 - $21,143	5,906 Added 36.45%	22,108 $46,000
Q3 2022 Nov 09, 2022	BUY	$2.95 - $4.83 $9,035 - $14,794	3,063 Added 23.31%	16,202 $51,000
Q2 2022 Aug 10, 2022	BUY	$3.13 - $8.83 $41,125 - $116,017	13,139 New	13,139 $43,000

128

59.3M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $278M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.